(E)-4-((5-Carboxy-3,3-dimethyl-1-octyl-3H-indol-1-ium-2-yl)methylene)-2-(((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate

Catalog No. :
ACMYIU695
CAS No. :
951248-19-4
Molecular Formula :
C37H44N2O4
Molecular Weight :
580.77

IUPAC Name:(E)-4-((5-carboxy-3,3-dimethyl-1-octyl-3H-indol-1-ium-2-yl)methylene)-2-(((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate

(E)-4-((5-Carboxy-3,3-dimethyl-1-octyl-3H-indol-1-ium-2-yl)methylene)-2-(((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-4-((5-Carboxy-3,3-dimethyl-1-octyl-3H-indol-1-ium-2-yl)methylene)-2-(((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate
IUPAC Name(E)-4-((5-carboxy-3,3-dimethyl-1-octyl-3H-indol-1-ium-2-yl)methylene)-2-(((E)-1-ethyl-3,3-dimethylindolin-2-ylidene)methyl)-3-oxocyclobut-1-en-1-olate
Molecular FormulaC37H44N2O4
Molecular Weight580.77
SMILES[O-]C1=C(/C=C2N(CC)C3=C(C=CC=C3)C/2(C)C)C(/C1=C/C4=[N+](CCCCCCCC)C5=C(C=C(C(O)=O)C=C5)C4(C)C)=O
InChI KeyGDYMYQRJZQFQCX-UHFFFAOYSA-N
Synonym( E )-4-((5-carboxy-3,3-diMethyl-1-octyl-3H-indoliuM-2-yl)Methylene)-2-((E )-(1-ethyl-3,3-diMethylindolin-2-ylidene)Methyl)-3-oxocyclobut-1-enolate;SQ01
CAS No.951248-19-4

Synthetic Route by SureRoute

1. ACMYIU695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMYIU695 route product structure diagram
    ACMYIU695951248-19-4
Inquiry

2. ACMYIU695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMYIU695 route product structure diagram
    ACMYIU695951248-19-4
Inquiry

Comments (0)